Tag: Anonymization

TrialAssure cubes divider
CCI

The Evolving Challenge of Pinpointing CCI in Clinical Documents

Read More
EMA Policy 0070

EMA Policy 0070 Relaunch Happening in September 2023: What You Need to Know! 

Read More
Company Confidential Information (CCI) Insights for Anonymization and Redaction in the Pharmaceutical Industry image trialassure

Company Confidential Information (CCI) Insights for Anonymization and Redaction in the Pharmaceutical Industry  

Read More
trialassure data sharing EMA COVID-19 assessments Clinical Trials Information System (CTIS), a new European trial registry due CTIS EU Clinical Trial Regulation

Latest Release of TrialAssure ANONYMIZE for Documents Saves up to 80 Percent of Effort in PDF Document Anonymization and Redaction for Regulated Pharmaceutical Industry Documents

Read More

FDA Furthers Transparency Push with CSR Release Pilot

Read More
trialassure data sharing EMA COVID-19 assessments Clinical Trials Information System (CTIS), a new European trial registry due CTIS EU Clinical Trial Regulation

This week in transparency news: February 8 – February 21, 2020

Read More
Outsourcing-Pharma released a State of the Industry report that sheds light on the global pharmaceutical industry. One of the key findings in the report showed that more than half of survey respondents believe that industry initiatives will lead to greater transparency. The report points to a new pilot program launched earlier this year by the FDA to increase transparency. Clinical Trial Transparency Software client feedback

This week in transparency news: June 1 – June 7, 2019

Read More
Get in Touch

Looking to streamline your clinical trial disclosure and transparency efforts?

TrialAssure is ready to help your organization embark on a Transparency Transformation!

To learn more about the TrialAssure Transparency Suite, specific products, or our company, contact us below.

Yes, please send me more information about TrialAssure.